Comparison of two methods of naloxone administration on improvement of clinical manifestations in patients with opium poisoning.

Phase 3

Recruiting

• Conditions: Opioid dependence.; Opioid dependence with intoxication; F11.22

• Registration Number: IRCT20110514006481N14
• Lead Sponsor: Semnan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Known opium toxicity
Spontaneous breathing more than 6 breath per minute
Age above 15 years old

Exclusion Criteria

Nose bleeding
Unstable hemodynamic
Allergy to naloxone

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
evel of consciousness. Timepoint: 5 min, 10 min, 15 min and 20 min after naloxone administration. Method of measurement: Glasgow Coma Scale.;Vital signs. Timepoint: 5 min, 10 min and 20 min after naloxone administration. Method of measurement: Ward monitor.;Clinical opiate withdrawal signs. Timepoint: 5 min, 10 min and 20 min after naloxone administration. Method of measurement: Clinical Opiate Withdrawal Scale (COWS).